Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Non-Hodgkin's Lymphoma
NCT00003498Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Oct 1997
- Primary completion
- Feb 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in non-Hodgkin lymphoma (NHL), sponsored by Burzynski Research Institute. Started Oct 1997; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003498.